Beijing's SL Pharma and Canada's PnuVax Form Vaccine, Antibody JV

SHANGHAI - Beijing's SL Pharmaceutical announced it will invest CAD $20 million to form a joint venture in Ontario, Canada with Canadian partner PnuVax Incorporated.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip